Meghna Das

Meghna Das is an experienced professional specializing in early commercial and value strategy within the AI-powered TechBio sector, focusing on oncology, hematology, and rare diseases. Currently serving as the Executive Director of Commercial Strategy and Intelligence at Recursion, Meghna has held significant roles in various organizations, including Director of Early Commercial and Clinical Strategy at Exscientia and multiple positions at ZS, where they developed expertise in pipeline strategy and commercial excellence. Meghna has also contributed to public health initiatives through strategic roles with UNDP and gained insights into consumer technology as a research analyst. They hold a degree from Delhi University, completed in 2014.